Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Yutaka, MIDORIKAWA"'
Autor:
Mitsuhiko Moriyama, Tatsuo Kanda, Yutaka Midorikawa, Hiroshi Matsumura, Ryota Masuzaki, Hitomi Nakamura, Masahiro Ogawa, Shunichi Matsuoka, Toshikatu Shibata, Motomi Yamazaki, Kazumichi Kuroda, Hisashi Nakayama, Tokio Higaki, Kazunori Kanemaru, Toshio Miki, Masahiko Sugitani, Tadatoshi Takayama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-21 (2022)
Abstract Recently, we reported that extent of proliferation of atypical hepatocytes (atypical hepatocytes) was most important histological risk factor for development of hepatocellular carcinoma (HCC) from chronic hepatitis C or liver cirrhosis. Here
Externí odkaz:
https://doaj.org/article/27e6f2d8468c4fb0b2d055a0dbb1b956
Autor:
Peipei Song, Yutaka Midorikawa, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Osamu Aramaki, Shintaro Yamazaki, Masaru Aoki, Kenichi Teramoto, Tadatoshi Takayama
Publikováno v:
Cancer Medicine, Vol 8, Iss 13, Pp 5862-5871 (2019)
Abstract Combined hepatocellular‐cholangiocarcinoma (cHCC‐CC) and intrahepatic cholangiocarcinoma (ICC) are classified into one category, but comparison of prognosis of the two carcinomas remains controversial. The aim of the current study was to
Externí odkaz:
https://doaj.org/article/264ab24e4b6e40e5ba289c16eea618af
Autor:
Yutaka Midorikawa, Tadatoshi Takayama, Hisashi Nakayama, Tokio Higaki, Masamichi Moriguchi, Kyoji Moriya, Tatsuo Kanda, Shunichi Matsuoka, Mitsuhiko Moriyama
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Prior hepatitis B virus infection (PBI) may increase the risk of developing hepatocellular carcinoma (HCC), but the impact of PBI on clinical outcomes following treatment for HCC remains unknown. The aim of this study was to clari
Externí odkaz:
https://doaj.org/article/b557d7695cce46f680249677bc49503a
Autor:
Yutaka Midorikawa1 mido-tky@umin.ac.jp
Publikováno v:
BioScience Trends. Jun2022, Vol. 16 Issue 3, p189-197. 9p.
Autor:
Yusuke Mitsuka, Yutaka Midorikawa, Hayato Abe, Naoki Matsumoto, Mitsuhiko Moriyama, Hiroki Haradome, Masahiko Sugitani, Shingo Tsuji, Tadatoshi Takayama
Publikováno v:
BMC Gastroenterology, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Liver stiffness measurement (LSM) has recently become available for assessment of liver fibrosis. We aimed to develop a prediction model for liver fibrosis using clinical variables, including LSM. Methods We performed a prospectiv
Externí odkaz:
https://doaj.org/article/d7912ade8fa3404bb7a52adebab594cd
Autor:
Nao, Yoshida, Yutaka, Midorikawa, Tokio, Higaki, Hisashi, Nakayama, Masamichi, Moriguchi, Osamu, Aramaki, Shingo, Tsuji, Yukiyasu, Okamura, Tadatoshi, Takayama
Publikováno v:
World Journal of Surgery. 46:1134-1140
We aimed to validate our algorithm for resecting Hepatocellular carcinoma (HCC) in the caudate lobe based on tumor location, tumor size, and indocyanine green clearance rate.Patients who underwent curative resections for solitary HCC in the caudate l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ebda876cb68a7487f848af5dc14dd1
https://doi.org/10.1007/s00268-022-06453-9
https://doi.org/10.1007/s00268-022-06453-9
Autor:
Hiroyuki Aburatani, Tadatoshi Takayama, Genta Nagae, Tatsuhiro Shibata, David A. Wheeler, Masahiko Sugitani, Chad J. Creighton, Kyle R. Covington, Shumpei Ishikawa, Hiroto Katoh, Takanori Fujita, Shiro Fukuda, Hiroki Ueda, Akimasa Hayashi, Shingo Tsuji, Claire Renard-Guillet, Kenji Tatsuno, Shogo Yamamoto, Yutaka Midorikawa
Table S1 shows Clinical features. Table S2 shows Patient/sample information and NGS statistics. Table S3 shows Methylation status of CpG sites of WNT targets with CTNNB1 mutation. Table S4 shows Chromosomal aberrations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bdff4215192e5d93d37f56f1e9bc81e
https://doi.org/10.1158/0008-5472.22426225
https://doi.org/10.1158/0008-5472.22426225
Autor:
Hiroyuki Aburatani, Tadatoshi Takayama, Genta Nagae, Tatsuhiro Shibata, David A. Wheeler, Masahiko Sugitani, Chad J. Creighton, Kyle R. Covington, Shumpei Ishikawa, Hiroto Katoh, Takanori Fujita, Shiro Fukuda, Hiroki Ueda, Akimasa Hayashi, Shingo Tsuji, Claire Renard-Guillet, Kenji Tatsuno, Shogo Yamamoto, Yutaka Midorikawa
Supplementary Figure legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c20ca7a67d916e8e01d34e3005fa2c
https://doi.org/10.1158/0008-5472.22426234
https://doi.org/10.1158/0008-5472.22426234
Autor:
Hiroyuki Aburatani, Kyoji Moriya, Kazuhiko Koike, Hayato Nakagawa, Mitsuhiko Moriyama, Genta Nagae, Shogo Yamamoto, Tadatoshi Takayama, Yutaka Midorikawa, Kenji Tatsuno
Purpose:Hepatitis B viral (HBV) DNA is frequently integrated into the genomes of hepatocellular carcinoma (HCC) in patients with chronic HBV infection (chronic HBV, hereafter), whereas the frequency of HBV integration in patients after the disappeara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::402065673533806822daf6580799fdf7
https://doi.org/10.1158/1078-0432.c.6527726.v1
https://doi.org/10.1158/1078-0432.c.6527726.v1
Autor:
Atsushi Kaneda, Hiroyuki Aburatani, Yasuyuki Seto, Hirohiko Sakamoto, Yoji Nishimura, Yutaka Midorikawa, Takayuki Isagawa, Shingo Tsuji, Genta Nagae, Hiroshi Hayashi, Kiwamu Akagi, Koichi Yagi
Purpose: Whereas the CpG island methylator phenotype (CIMP) in colorectal cancer associates with microsatellite instability (MSI)-high and BRAF-mutation(+), the existence of an intermediate-methylation subgroup associated with KRAS-mutation(+) is con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd90e15c9dfbed583592b8a49c71305
https://doi.org/10.1158/1078-0432.c.6518326
https://doi.org/10.1158/1078-0432.c.6518326